Starlance Pharmaceuticals

Ceftrastar 1.5 gm Injection

Ceftrastar 1.5 gm Injection is a powerful combination of Ceftriaxone and Sulbactam, formulated to provide broad-spectrum antibacterial coverage. Ceftriaxone, a third-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, while Sulbactam enhances its efficacy by inhibiting beta-lactamase enzymes, ensuring effective action against resistant bacterial strains.

• Composition: Ceftriaxone + Sulbactam (1.5 gm)
• Indications: Effective in treating severe bacterial infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, abdominal infections, and more.
• Dosage Form: Sterile injection for intravenous or intramuscular administration.

Marketed by Starlance Pharmaceuticals, Ceftrastar 1.5 gm Injection ensures trusted and efficient treatment for combating bacterial infections.